Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma
Clinical trial NCT03567135 · UNKNOWN
Trial details
- NCT number
- NCT03567135
- Sponsor
- Fuzhou General Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2017-10-01
- Primary completion
- 2019-04-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.